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tion, liver cirrhosis (Child-Pugh class B), and hepatocel-
lular carcinoma (HCC; T3aN0M0, stage IIIA) presented at
our institution with severe left shoulder pain that he had
been experiencing for 1 week. He reported no preceding
trauma or fall. A physical examination showed a
restricted active range of motion in all directions, se-
vere local tenderness, and crepitus in the left shoulder.
Radiography showed a bony destruction of the superior
border of the scapula and acromion (Fig. 1A). A
computed tomography scan of his chest showed several
nodules in his left lung and an ill-defined osteolytic
lesion extending from the scapular body to the acromion
(Fig. 1B), indicating a pathological fracture. A whole-
body bone scan showed intense tracer uptake by the
acromion and superior and medial borders of the scapula
(Fig. 1C), indicating bone metastasis. The final diagnosis
was HCC with extrahepatic metastases to the left lung
and left scapula. The patient received palliative radio-
therapy and care.
HCC is endemic in Southeast Asia, including Taiwan,
where chronic infection with hepatitis B or C virus is
common.1 Chronic viral hepatitis leads to the develop-
ment and progression of liver cirrhosis; the risk of devel-
oping HCC in patients with cirrhosis is high among the
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tases in establishing the appropriate treatment plan for
patients with HCC. The most common sites of extrahe-
patic metastasis from HCC are the lungs, abdominal lymph
nodes, bones, and adrenal glands.2 The prognosis of pa-
tients with HCC who have extrahepatic metastases is
generally poor. The controllability of intrahepatic lesions
and the liver performance status are important prognostic
determinants in the majority of patients with HCC, rather
than the presence of extrahepatic metastases. However,
the poor prognosis of patients with HCC who have extra-
hepatic metastasis might not improve despite aggressive
treatment.
The increasing incidence of bone metastases detected
in patients with HCC is partly attributed to the prolonged
survival achieved because of progress in the early diag-
nosis and treatment of primary HCC. Bone metastases
from HCC are often multiple, with an osteolytic appear-
ance, and commonly involve the vertebrae, pelvis, ribs,
and skull.3 As bone metastases from HCC usually display a
rapid osteolytic process without obvious new bone for-
mation, using a whole-body bone scan to detect bone le-
sions gives rise to a high rate of false negative results.4
Metastasis of HCC to the scapula is very rare and may
cause pain, functional impairment, and pathological
fractures of the affected limb when it does occur. Bone
metastases to the shoulder girdle commonly originate
from breast, renal, and lung cancers, or myeloma. The
middle third and proximal third of the humerus are the
two most commonly involved sites.5 The main goals of
managing bone metastasis in our patient were to relieve
pain, prevent further complications, preserve residual
function, and improve his quality of life.Association. All rights reserved.
Figure 1 (A) Radiograph showing bony destruction of the superior border of the left scapula (long arrow) and part of the
acromion (short arrow). (B) Chest computed tomography scan showing an osteolytic lesion in the left scapular body (arrows). (C)
Whole-body bone scan showing intense tracer uptake by the acromion, coracoid process, and superior and medial borders of the
left scapula (arrow).
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